MDR 1.04% 47.5¢ medadvisor limited

Ann: MedAdvisor Partners with US Company iHealth Labs, page-26

  1. 62 Posts.
    I think some people may not appreciate the strategic significance of this announcement.

    They are in the process of building out the MedAdvisor patient App as a far more comprehensive patient-facing healthcare platform.

    So this means not only medication management functionality, but also the additional features associated with the OzDocsOnline acquisition (online appointments, repeat scripts, repeat referrals, test results, eConsults with a GP which may incorporate Telehealth and later on even artificial intelligence in the form of symptom checkers as in Babylon Health), and now real-time data from connected health devices (again which may eventually feed into artificial intelligence algorithms easily incorporated into the App).

    This is a long-term play and needs a long-term vision.

    They are 1-2 years ahead of their nearest competitors in this patient App space in Australia.

    They have numerous revenue channels in place and in the pipeline, and have shown pretty good revenue growth to date.
    Last edited by DoctorofStocks: 30/05/17
 
watchlist Created with Sketch. Add MDR (ASX) to my watchlist
(20min delay)
Last
47.5¢
Change
-0.005(1.04%)
Mkt cap ! $261.5M
Open High Low Value Volume
49.0¢ 50.0¢ 47.5¢ $168.0K 342.4K

Buyers (Bids)

No. Vol. Price($)
1 45 48.0¢
 

Sellers (Offers)

Price($) Vol. No.
50.0¢ 597363 14
View Market Depth
Last trade - 15.55pm 11/07/2024 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.